TSPYL1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.119200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.975400E-01
Normal-vs-Stage2
1.062390E-01
Normal-vs-Stage3
8.700300E-02
Normal-vs-Stage4
8.805600E-01
Stage1-vs-Stage2
2.564800E-01
Stage1-vs-Stage3
6.794400E-02
Stage1-vs-Stage4
5.779400E-01
Stage2-vs-Stage3
1.315630E-01
Stage2-vs-Stage4
1.035000E-01
Stage3-vs-Stage4
7.895100E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.149000E-01
Normal-vs-AfricanAmerican
7.723000E-01
Normal-vs-Asian
2.705600E-01
Caucasian-vs-AfricanAmerican
3.643600E-01
Caucasian-vs-Asian
7.156000E-01
AfricanAmerican-vs-Asian
3.023800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.946400E-01
Normal-vs-Female
3.507000E-01
Male-vs-Female
9.615000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.839800E-01
Normal-vs-Age(41-60Yrs)
4.216000E-01
Normal-vs-Age(61-80Yrs)
3.153200E-01
Normal-vs-Age(81-100Yrs)
5.939800E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.107600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.824400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.484400E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.438990E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.366300E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.585800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.926000E-02
Normal-vs-Daily Drinker
3.043800E-02
Normal-vs-Weekly Drinker
9.807900E-02
Normal-vs-Occasional Drinker
9.049200E-01
Normal-vs-Social Drinker
3.334800E-01
Non Drinker-vs-Daily Drinker
4.119200E-01
Non Drinker-vs-Weekly Drinker
9.866600E-01
Non Drinker-vs-Occasional Drinker
1.627790E-01
Non Drinker-vs-Social Drinker
4.512200E-01
Daily Drinker-vs-Weekly Drinker
4.724000E-01
Daily Drinker-vs-Occasional Drinker
8.761600E-02
Daily Drinker-vs-Social Drinker
1.770560E-01
Weekly Drinker-vs-Occasional Drinker
1.697020E-01
Weekly Drinker-vs-Social Drinker
5.161400E-01
Occasional Drinker-vs-Social Drinker
3.555400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.444200E-01
Normal-vs-Grade 2
6.323700E-02
Normal-vs-Grade 3
4.474200E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.228830E-01
Grade 1-vs-Grade 3
9.147900E-02
Grade 1-vs-Grade 4
2.444200E-01
Grade 2-vs-Grade 3
6.519000E-01
Grade 2-vs-Grade 4
6.323700E-02
Grade 3-vs-Grade 4
4.474200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.172000E-01
Normal-vs-NonDiabetic
3.023600E-01
Diabetic-vs-NonDiabetic
6.898200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.758400E-02
Normal-vs-NoPancreatitis
3.284000E-01
Pancreatitis-vs-NoPancreatitis
3.577400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.748600E-01
Normal-vs-N1
9.236400E-02
N0-vs-N1
1.083360E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.011550E-01
Normal-vs-TP53-NonMutant
9.073200E-01
TP53-Mutant-vs-TP53-NonMutant
7.603400E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
